About OWL Genomics
OWL Genomics is a spin-off biotechnology company founded in 2002 with the aim of providing leading-edge applications in human health care, with innovative and pioneering technologies in the areas of diagnosis and treatment. The scientific expertise of Dr. José María Mato, and the studies that he has carried out during the last twenty years on hepatic diseases has placed OWL Genomics in a privileged position in the market of the hepatic diagnosis.
Our primary goal is the identification and validation of diagnostic biomarkers and therapeutic targets with the aim of developing diagnostic and treatment systems. To accomplish this we utilise innovative technology in genomics, proteomics, metabolomics and bioinformatics and have established a complete and highly productive platform which supports the advance of our developments.
- Focus : Manufacturer
- Industry : Biotechnology
Product portfolio of OWL Genomics
News about OWL Genomics
Here you will find OWL Genomics
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
